Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124257) titled 'KEYMAKER-U01 Substudy 01F: A Phase 1b/2 Umbrella Study With Rolling Arms of Investigational Agents for Previously Treated Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations' on May 9.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
Condition:
with advanced or metastatic nonsquamous NSCLC with KRAS G12C mutations, whohave received 1-2 lines of prior anti-PD-1/PD-L1 therapy and platinum-based chemotherapywithout prior KRAS inhibitor t...